Hypoxia-induced pathways in breast cancer

Microscopy Research and Technique

Volumn 59, Issue 1, 2002, Pages 41-48

  Goonewardene, T I ^a   Sowter, H M ^a   Harris, A L ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Carbonic anhydrases; Glycolysis; HIF 1; HIF 2; Hypoxia

Indexed keywords

DISEASES; PATHOLOGY; TUMORS;

ANGIOGENESIS; BREAST CANCER; GLYCOLYSIS; HIF-1; HIF-2; HYPOXIA; HYPOXIA-INDUCIBLE FACTORS; MOLECULAR PATHWAYS; SOLID TUMORS; TUMOR GROWTH;

CARBONIC ANHYDRASE;

CARBONATE DEHYDRATASE; DNA; HYPOXIA INDUCIBLE FACTOR 1;

ADAPTATION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; DNA BINDING; GENE CONTROL; GLYCOLYSIS; HUMAN; HYPOXIA; PH; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR GROWTH;

EID: 0036786890     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10175     Document Type: Article

References (123)

1. Adams MB, McMillen IC. 2000. Actions of hypoxia on catecholamine synthetic enzyme mRNA expression before and after development of adrenal innervation in the sheep fetus. J Physiol 529:519-531.
2. Bae SK, Bae MH, Ahn MY, Son M, Lee Y, Bae MK, Lee OH, Park BC, Kim KW. 1999. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res 59:5989-5994.
3. Barnes PJ, Karin M. 1997. Nuclear factor-kappa B, A pivotal transcription factor in chronic inflammatory disease. N Engl J Med 336:1066-1071.
4. Benjamin IJ, Horie S, Greenberg ML, Alpern RJ, Williams RS. 1992. Induction of stress proteins in cultured myogenic cells. Molecular signals for the activation of heat shock transcription factor during ischemia. J Clin Invest 89:1685-1689.
5. Binder C, Binder L, Marx D, Schauer A, Hiddemann W. 1997. Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. Anticancer Res 17:4299-4304.
6. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L. 1998. p53 inhibits hypoxia-inducible factor stimulated transcription. J Biol Chem 273:11995-11998.
7. Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL. 2000. Relationship of hypoxia-inducible factor (HIF)-1α and HIF-2α expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 60:7106-7113.
8. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, van der Wall E. 2001. Levels of hypoxia-inducible factor-lalpha during breast carcinogenesis. J Natl Cancer Inst 93:309-314.
9. Brizel DM, Dodge RK, Clough RW, Dewhirst MW. 1999. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 53:113-117.
10. Brown JM, Giaccia AJ. 1998. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58:1408-1416.
11. Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-257.
12. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E, Keshet E. 1998. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 394:485-490.
13. Chaplin DJ, Trotter MJ. 1990. The nature of tumor hypoxia: implications for therapy. Prog Clin Biol Res 354B:81-92.
14. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D. 1990. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535-1545.
15. De Paulsen N, Brychzy A, Fournier MC, Klausner RD, Gnarra JR, Pause A, Lee S. 2001. Role of transforming growth factor-alpha in von Hippel Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci USA 98:1387-1392.
16. Ebert BL, Gleadle JM, O'Rourke JF, Bartlett SM, Poulton J, Ratcliffe PJ. 1996. Isoenzyme specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. Biochem J 313:809-814.
17. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y. 1997. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94:4273-4278.
18. Epstein AC, Gleadle JM, McNeil LA, Hewitson KS, O'Rourke J, Mole DR, Mukerji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54.
19. Estes SD, Stoler DL, Anderson GR. 1995. Anoxic induction of a sarcoma virus-related VL30 retrotransposon is mediated by a cisacting element which binds hypoxia-inducible factor 1 and an anoxia-inducible factor. J Virol 69:6335-6341.
20. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL. 1999. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59:3915-3918.
21. Fox SB, Leek RD, Bliss J, Mansi JL, Gusterson B, Gatter KC, Harris AL. 1997. Association of tumour angiogenesis with bone marrow micrometastases in breast cancer patients. J Natl Cancer Inst 89:1044-1049.
22. Galindo, M, Santiago B, Alcami J, Rivero M, Martin-Serrano J. Pablos JL. 2001. Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts. Clin Exp Immunol 123:36-41.
23. Garayoa M, Martinez A, Lee S, Pio R, An WG, Neckers L, Trepel J, Montuenga LM, Ryan H, Johnson R, Gassmann M, Cuttitta F. 2000. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol 14:848-862.
24. Giaccia AJ, Auger EA, Koong, A, Terris DJ, Minchinton AI, Hahn GM, Brown JM. 1992. Activation of the heat shock transcription factor by hypoxia in normal and tumor cell lines in vivo and in vitro. Int J Radiat Oncol Biol Phys 23:891-897.
25. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ Jr, Giaccia AJ. 1994. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14:6264-6277.
26. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88-91.
27. Graham CH, Fitzpatrick TE, McCrae KR. 1998. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 93:3300-3307.
28. Graven KK, Troxler RF, Kornfeld H, Panchenko MV, Farber HW. 1994. Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J Biol Chem 269:24446-24453.
29. Green SL, Freiberg RA, Giaccia AJ. 2001. P21 (Cipl) and p27 (Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol Cell Biol 21:1196-1206.
30. Guidi AJ, Berry DA, Broadwater G. 2000. Association of angiogenesis in lymph node metastases with outcome in breast cancer patients. J Natl Cancer Inst 92:486-492.
31. Gunningham SP, Currie MJ, Han C, Turner K, Scott PA, Robinson BA, Harris AL, Fox SB. 2001. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia. Cancer Res 61:3206-3211.
32. Hanahan D, Christofori G, Naik P, Arbeit J. 1996. Transgenic mouse models of tumor angiogenesis: the angiogenic switch, its molecular controls, and prospect for therapeutic models. Eur J Cancer 32:2386-2393.
33. Hockel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, Knapstein PG, Vaupel P. 1993. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26:45-50.
34. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. 1996a. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509-4515.
35. Hockel M, Schlenger K, Mitze M, Schaffer U, Vaupel P. 1996b. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 6:3-9.
36. Hockel M, Schlenger K, Hockel S, Vaupel P. 1999. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59:4525-4528.
37. Hu J, Discher DJ, Bishopric NH, Webster KA. 1998. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun 245:894-899.
38. Huang LE, Gu J, Schau M, Bunn HE. 1998. Regulation of hypoxiainducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteosome pathway. Proc Natl Acad Sci USA 95:7987-7992.
39. Ivan M, Kaelin WG Jr. 2001. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev 11:27-34.
40. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara J, Lane W, Kaelin W Jr. 2001. HIF-1α targeted for VHL-mediated destruction by proline hydroxylation: implications for 02 sensing. Science 292:464-468.
41. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL. 1998. Cellular and developmental control of 02 homeostasis by hypoxiainducible factor 1alpha. Genes Dev 12:149-162.
42. Jaakkola P, Mole DR, Tian YM, Wilson M, Gielbert J, Gaskell SJ, von Kriegsheim AV, Hebestreit HF, Mukerji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. 2001. Targeting of HIF-1alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472.
43. Jiang BH, Agani F, Passaniti A, Semenza GL. 1997. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57:5328-5335.
44. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. 1999. Regulation of the hypoxia-inducible factor 1α by the ubiquitin-proteosome pathway. J Biol Chem 274:6519-6525.
45. Kietzmann T, Roth U, Jungermann K. 1999. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94:4177-4185.
46. Kim KW, Bae SK, Lee OH, Bae MH, Lee MJ, Park, BC. 1998. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res 58:348-351.
47. Knies U, Harris AL. 2000. Hypoxia signaling in tumor angiogenesis. Emerging Ther Targets 4:361-375.
48. Koong AC, Chen EY, Lee AS, Brown JM, Giaccia AJ. 1994. Increased cytotoxicity of chronic hypoxic cells by molecular inhibition of GRP78 induction. Int J Radiat Oncol Biol Phys 28:661-666.
49. Kourembanas S, Hannan RL, Faller DV. 1990. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest 86:670-674.
50. Kraggerud SM, Sandvik JA, Pettersen EO. 1995. Regulation of protein synthesis in human cells exposed to extreme hypoxia. Anticancer Res 15:683-686.
51. Laderoute KR, Grant TD, Murphy BJ, Sutherland RM. 1992. Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen. Int J Cancer 52:428-432.
52. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. 2001. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21:3995-4004.
53. Lee AH, Tannock IF. 1998. Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells. Cancer Res 58:1901-1909.
54. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM. 1997. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272:5375-5381.
55. Lee WH, Wang GM, Yang XL, Seaman LB, Vannucci SI. 1999. Perinatal hypoxia-ischaemia decreased neuronal but increased cerebral vascular endothelial IGFBP3 expression. Endocrine 11:181-188.
56. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625-4629.
57. Leek RD, Landers R, Fox SB, Ng F, Harris AL, Lewis CE. 1998. Association of tumor necrosis factoralpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 77:2246-2251.
58. Leek RD, Hunt NC, Landers RJ, Lewis CE, Royds JA, Harris AL. 2000. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190:430-436.
59. Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, Bicknell R, Taylor M, Gatter KC, Harris AL. 2002. Relation of hypoxia-inducible factor 2α (HIF-2α) expression in tumor-infiltrative macrophages to tumor angiogenesis and oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res 62:1326-1329.
60. Linderholm B, Grankvist K, Wilking N, Johansson M, Tavelin B, Henriksson R. 2000. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. J Clin Oncol 18:1423-1431.
61. Masson N, William C, Maxwell PH, Pugh CW, Ratcliffe PJ. 2001. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J 20:5197-5206.
62. Mathupala SP, Rempel A, Pedersen PL. 2001. Glucose catabolism in cancer cells: Identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem 276:43407-43412.
63. Maxwell PH, Pugh CW, Ratcliffe PJ. 1993. Inducible operation of the erythropoetin 3′enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci USA 90:2423-2427.
64. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
65. Maxwell PH, Pugh CW, Ratcliffe PJ. 2001. Activation of the HIF pathway in cancer. Curr Opin Genet Dev 11:293-299.
66. Mazurek S, Michel A, Eigenbrodt E. 1997. Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. J Biol Chem 272:4941-4952.
67. Mukhopadhyay CK, Mazumder B, Fox PL. 2000. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 275:21048-21054.
68. Nagao M, Ebert BL, Ratcliffe PJ, Pugh CW. 1996. Drosophila melanogaster SL2 cells contain a hypoxically inducible DNA binding complex, which recognizes mammalian HIF-binding sites. FEBS Lett 387:161-166.
69. Oh H, Tagaki H, Sumuza K, Otani A, Matsumura M, Honda Y. 1999. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274:15732-15739.
70. O'Rourke JF, Pugh CW, Bartlett SM, Ratcliffe PJ. 1996. Identification of hypoxically inducible mRNAs in HeLa cells using differential display PCR. Role of hypoxia-inducible factor-1. Eur J Biochem 241:403-410.
71. Palmer LA, Semenza GL, Stoler MH, Johns RA. 1998. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol 274:L212-219.
72. Payen E, Bettan M, Henri A, Tomkiewitcz E, Houque A, Kuzniak I, Zuber J, Scherman D, Beuzard Y. 2001. Oxygen tension and a pharmacological switch in the regulation of transgene expression for gene therapy. J Gene Med 3:498-504.
73. Pegram MD, Pauletti G, Slamon DJ. 1998. HER-2/neu as a predictive marker of response to breast cancer therapy. Breast Cancer Res Treat 52:65-77.
74. Price BD, Calderwood SK. 1992. Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Res 52:3814-3817.
75. Pugh CW, Tan CC, Jones RW, Ratcliffe PJ. 1991. Functional analysis of an oxygen-regulated transcriptional enhancer lying 3′ to the mouse erythopoietin gene. Proc Natl Acad Sci USA 88:10553-10557.
76. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ. 1997. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J Biol Chem 272:11205-11214.
77. Reynolds TY, Rockwell S, Glazer PM. 1996. Genetic instability induced by the tumour microenvironment. Cancer Res 56:5754-5757.
78. Rilke F, Colnaghi MI, Cascinelli N, Andreola S, Baldini MT, Bufalino R, Della Porta G, Menard S, Pierotti MA, Testori A. 1991. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer 49:44-49.
79. Ryan HE, Lo J, Johnson RS. 1998. HIF-1alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17:3005-3015.
80. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60:4010-4015.
81. Saarnio J, Parkillila S, Parkilla AK, Hauikpuro K, Pastorekova S, Pastorek J, Kairaluoma MI, Karttunen TJ. 1998. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 153:279-285.
82. Salceda S, Caro J. 1997. Hypoxia-inducible factor 1alpha (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272:22642-22647.
83. Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN, Runge MS. 1997. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272:601-608.
84. Seimiya H, Tanji M, Oh-hara T, Tomida A, Naasani I, Tsuruo T. 1999. Hypoxia up-regulates telomerase activity via mitogen-activated protein kinase signaling in human solid tumor cells. Biochem Biophys Res Commun 260:365-370.
85. Semenza GL. 2000a. HIF-1 and human disease: one highly involved factor. Genes Dev 14:1983-1991.
86. Semenza GL. 2000b. HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev 19:59-65.
87. Semenza GL, Wang GL. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoeitin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447-5454.
88. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE. 1991. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA 88:5680-5684.
89. Semenza GL, Roth PH, Fang HM, Wang GL. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-induc ible factor 1. J Biol Chem 269:23757-23763.
90. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529-32537.
91. Shim H, Dolde C, Lewis BC, Wu C, Dang G, Jungmann RA, Dalla-Favera R, Dang CV. 1997. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci USA 94:6658-6663.
92. Shweiki D, Itin A, Soffer D, Keshet E. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
93. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
94. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL. 2001. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 61:6669-6673.
95. Suzuki H, Tomida A, Tsuruo T. 2001. Dephosphorylated hypoxia-inducible factor lalpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 20:5779-5788.
96. Tacchini L, Bianchi L, Bernelli-Zazzera A, Cairo G. 1999. Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem 274:24142-24146.
97. Takahata S, Sogawa K, Kobayashi A, Ema M, Mimura J, Ozaki N, Fujii-Kuriyama Y. 1998. Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1α, HLF, and clock. Biochem Biophys Res Commun 248:789-794.
98. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. 2000. The expression and distribution of the hypoxiainducible factors HIF-1α and HIF-2α in normal human tissues, cancers and tumor-associated macrophages. Am J Pathol 157:411-421.
99. Tamm M, Bihl M, Eickelberg O, Stulz P, Perruchoud AP, Roth M. 1998. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. Am J Respir Cell Mol Biol 19:653-661.
100. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M. 1994. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 75:426-433.
101. Taylor CT, Colgan SP. 1999. Therapeutic targets for hypoxia-elicited pathways. Pharm Res 16:1498-1505.
102. Tureci O, Sahin U, Vollmar E, Siemer S, Gottert E, Seitz G, Parkilla AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS. 1998. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA 95:7608-7613.
103. Vaupel P, Fortmeyer HP, Runkel S, Kallinowski F. 1987. Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res 47:3496-3503.
104. Vaupel P, Schlenger K, Knoop C, Hockel M. 1991. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 51:3316-3322.
105. Vaupel P, Kelleher DK, Hockel M. 2001 Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 28(Suppl 8):29-35.
106. Vaziri ND. 2001. Erythropoietin and transferrin metabolism in nephrotic syndrome. Am J Kidney Dis 38:1-8.
107. Vermylen P, Roufosse C, Burny A, Verhest A, Bosschaerts T, Pastorekova S, Ninane V, Sculier JP. 1999. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell carcinoma. Eur Resp J 14:806-811.
108. Walton HL, Corjay MH, Mohamed SN, Mousa SA, Santomenna LD, Reilly TM. 2000. Hypoxia induces differential expression of the integrin receptors alpha (v)(beta3) and alpha (v)(beta5) in cultured human endothelial cells. J Cell Biochem 78:674-680.
109. Wang GL, Semenza GL. 1993a. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90:4304-4308.
110. Wang GL, Semenza GL. 1993b. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:3610-3615.
111. Wang GL, Jiang BH, Rue EA, Semenza G. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510-5514.
112. Weber G, Stubbs M, Morris HP. 1971. Metabolism of hepatomas of different growth rates in situ and during ischemia. Cancer Res 31:2177-2183.
113. Webster KA, Discher DJ, Bishopric NH. 1993. Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J Biol Chem 68:16852-16855.
114. Weidner N, Semple JP, Welch WR, Folkman J. 1991. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8.
115. Wiener CM, Booth G, Semenza GL. 1996. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225:485-488.
116. Willam C, Koehne P, Jurgensen JS, Grafe M, Wagner KD, Bachmann S, Frei U, Eckardt KU. 2000. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ Res 83:370-377.
117. Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. 2000a. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 19:6297-6305.
118. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. 2000b. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60:7075-7083.
119. Wykoff CC, Beasley N, Watson PH, Campo L, Chia SK, English R, Pastorek J, Sly WS, Ratcliffe P, Harris AL. 2001. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158:1011-1019.
120. Yan SF, Zou YS, Gao Y, Zhai C, Mackman N, Lee SL, Milbrandt J, Pinsky D, Kisiel W, Stern D. 1998. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 95:8298-8303.
121. Younes M, Brown RW, Mody DR, Fernandez L, Laucirica R. 1995. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res 15:2895-2898.
122. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. 1998. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-lalpha/ARNT. EMBO J 17:5085-5094.
123. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. 1999. Overexpression of hypoxia-inducible factor lalpha in common human cancers and their metastases. Cancer Res 59:5830-5835.